Le Lézard
Classified in: Health, Business

CVS Health Announces Successful First Year of Aetna Integration at One Year Anniversary


WOONSOCKET, R.I., Dec. 5, 2019 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) today announced it has successfully completed the first year of combined operations following the acquisition of Aetna in late 2018. The combined company has met or exceeded its first-year integration goals while introducing new, consumer-focused offerings as a result of its unmatched capabilities. CVS Health remains on track to meet its most recent 2019 net synergy guidance and remains confident in its net synergy targets for 2020 and 2021.

CVS Health (PRNewsFoto/CVS Health)

"A full year of integration is a significant milestone in our long-term strategy to create the world's most consumer-centric health company," said Larry J. Merlo, President and CEO, CVS Health. "We're already seeing the benefits of our differentiated business model, which is delivering value to customers and patients across the country. I'm incredibly proud of the progress we've made, and I'm confident we will continue to raise the bar on what's possible in 2020."

CVS Health has been focused on four enterprise priorities to accelerate growth, as outlined at its Investor Day in June:

Merlo continued, "By executing on our strategy we've been able to develop and implement unique offerings that are resonating with consumers. Our HealthHUB® model, which launched in Houston this year and will expand to a projected 1,500 locations by the end of 2021, has already shown an ability to improve patient outcomes and enhance customer satisfaction. We've also invested in a suite of in-home and digital offerings to better meet consumers where they are, such as our home hemodialysis device which is the subject of a clinical trial to support a future request for FDA clearance, and new virtual health services available through the CVS Pharmacy app. What's good for consumer health will be good for business, and the early results back that up.

"The evolution of health care will accelerate in 2020, and we're extremely well-positioned to lead. The private sector, and CVS Health in particular, will be the engine that drives health care innovation next year and beyond."

About CVS Health
CVS Health is the nation's premier health innovation company helping people on their path to better health. Whether in one of its pharmacies or through its health services and plans, CVS Health is pioneering a bold new approach to total health by making quality care more affordable, accessible, simple and seamless. CVS Health is community-based and locally focused, engaging consumers with the care they need when and where they need it. The Company has approximately 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with more than 102 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. CVS Health also serves an estimated 38 million people through traditional, voluntary and consumer-directed health insurance products and related services, including rapidly expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Cautionary Statement Concerning Forward-Looking Statements
The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS Health Corporation. Statements in this press release that are forward-looking include information related to 2019 net synergy guidance and net synergy targets for 2020 and 2021, and information in Mr. Merlo's quoted statement. By their nature, all forward-looking statements involve risks and uncertainties. Actual results may differ materially from those contemplated by the forward-looking statements for a number of reasons as described in our Securities and Exchange Commission ("SEC") filings, including those set forth in the Risk Factors section and under the section entitled "Cautionary Statement Concerning Forward-Looking Statements" in our most recently filed Annual Report on Form 10-K and in our most recently filed Quarterly Report on Form 10-Q.

You are cautioned not to place undue reliance on CVS Health's forward-looking statements. These forward-looking statements are and will be based upon management's then-current views and assumptions regarding future events and operating performance, and are applicable only as of the dates of such statements. CVS Health does not assume any duty to update or revise forward-looking statements, whether as a result of new information, future events or otherwise, as of any future date.

Investor Contact:
Valerie Haertel
CVS Health
401-770-4050
Valerie.Haertel@CVSHealth.com

Media Contact:
T.J. Crawford
CVS Health
212-457-0583
CrawfordT2@aetna.com

SOURCE CVS Health


These press releases may also interest you

25 sep 2020
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Vaxart, Inc. . In early 2020, the Company, which focuses on...

25 sep 2020
Montage Resources Corporation WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Montage Resources Corporation in connection with the proposed acquisition of the company by...

25 sep 2020
The National Society of College Scholars (NSCS) is proud to announce a new community service partnership with The Alzheimer's Association. NSCS members will participate in a community service project through The Alzheimer's Association's Longest Day®...

25 sep 2020
Pomerantz LLP announces that a class action lawsuit has been filed against BioMarin Pharmaceuticals, Inc.  ("BioMarin" or the "Company") and certain of its officers.   The class action, filed in United States District Court for the Northern District...

25 sep 2020
Century Specialty Script, LLC ("Century"), a specialty pharmacy which provides an array of specific and personalized services in all pharmacy related matters, announced today that it has taken action after learning of a data security incident which...

25 sep 2020
ILJIN SNT Co., Ltd. ("ILJIN SNT") announces that, based on information contained in documents filed publicly by Aurinia Pharmaceuticals Inc. ("Aurinia"), ILJIN SNT has ceased to be an insider of Aurinia. On July 27, 2020, Aurinia completed an...



News published on 5 december 2019 at 08:30 and distributed by: